Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:39 AM UTC
| NCT Number | NCT06293898 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 280 participants |
| Active Locations | 17 sites in the US |
| Sponsor | SystImmune Inc. |
| Last Updated on CT.gov | March 23, 2026 (Mar 23, 2026) |
As of July 13, 2026: Clinical trial NCT06293898 is currently recruiting participants. This clinical trial study for endometrial cancer is actively seeking new participants at 17 locations across the United States. The study is sponsored by SystImmune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06293898 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06293898 was last updated Mar 23, 2026 (March 23, 2026). HelloStudys verifies this status automatically.